NVCR 总负债历史(2017–2026)
NovoCure Limited (NVCR) 各财年年末总负债(来自 SEC 财报)。
$463.9MFY2026 · FY2017 以来:$139.7M → $463.9M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2026 | $463.9M | -47.3% |
| FY2025 | $880.6M | +12.4% |
| FY2024 | $783.6M | +4.4% |
| FY2023 | $750.5M | +2.9% |
| FY2022 | $729.0M | +26.7% |
| FY2021 | $575.5M | +119.9% |
| FY2020 | $261.7M | +15.0% |
| FY2019 | $227.5M | +50.0% |
| FY2018 | $151.7M | +8.6% |
| FY2017 | $139.7M | — |
公司未直接申报总负债的年份,按同一财年年末的申报总资产 − 申报股东权益列示。
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议